Radical prostatectomy versus deferred treatment for localised prostate cancer (2020)

Peer-Reviewed Study · Vernooij RW, Lancee M, Cleves A, Dahm P, Bangma CH, Aben KK (Cochrane Database Syst Rev 2020;6:CD006590) · June 4, 2020

Vernooij RW et al., 2020-06-04: Cochrane review comparing radical prostatectomy with watchful waiting and with active monitoring in localised prostate cancer. It reports improved oncological outcomes against watchful waiting but markedly more incontinence and erectile dysfunction, and similar survival against active monitoring at up to 10 years.

RP compared with WW probably results in substantially improved oncological outcomes in men with localised prostate cancer but also markedly increases rates of urinary incontinence and erectile dysfunction.

Abstract (AUTHORS' CONCLUSIONS)

Vernooij RW et al., 2020-06-04: Cochrane review comparing radical prostatectomy with watchful waiting and with active monitoring in localised prostate cancer. It reports improved oncological outcomes against watchful waiting but markedly more incontinence and erectile dysfunction, and similar survival against active monitoring at up to 10 years. Funder: internal – IKNL (Netherlands), Velindre NHS Trust/Cardiff University, Minneapolis VA, Erasmus MC; 'No sources of support supplied' external. Conflicts: all authors 'none known'. No Cochrane review dedicated to active surveillance as such was located; this is the closest Cochrane comparison of treatment versus deferred treatment/active monitoring. Men in the watchful-waiting trials were largely diagnosed before PSA screening, which the authors say limits generalisability. PMC7270852. Study type: review.